Non-invasive central venous pressure monitoring in children
Official title: Non-invasive Central Venous Pressure Estimation in Pediatric Patients
Run by Compremium AG · NCT06885073 · Data updated 2026-11-12
We will test a new non-invasive ultrasound device (CPMX2) to see if it can measure central venous pressure in children who already have a central venous catheter or are undergoing cardiac catheterization.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 21 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Compremium AG Industry-sponsored |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Status | Recruiting |
| Started | March 10, 2025 |
| Main results expected | March 31, 2026 |
| Study ends | March 31, 2026 |
| Registry record updated | September 18, 2025 |
| Trial ID | NCT06885073 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children from birth to 21 years who already have a central venous catheter for CVP monitoring or are undergoing cardiac catheterization, weigh at least 2.5 kg, have accessible external jugular veins, and are clinically stable.
✕Probably not a fit
Patients unlikely to benefit include those under 2.5 kg, without a central venous catheter or inaccessible neck veins, with contraindicating neck skin lesions, active bleeding, or who are clinically unstable.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot interventional study will compare non-invasive venous occlusion pressure (VOP) readings from the CPMX2 ultrasound device with invasive central venous pressure (CVP) measurements in pediatric patients who already have a central venous catheter as part of standard care. The study will enroll patients from birth to 21 years old, with exclusions for very low weight, inaccessible neck veins, skin lesions, active bleeding, or clinical instability. Safety endpoints will document any device-related adverse events and feasibility endpoints will compare agreement between CPMX2 and invasive CVP values. The study is conducted at a single center (Children's National Hospital) and is intended to generate preliminary safety and performance data.
Why it matters
Potential benefit: If successful, the device could allow clinicians to measure CVP without placing a catheter, reducing risks like infection, thrombosis, and pneumothorax.
How similar studies have gone: Related non-invasive ultrasound and VOP methods have shown encouraging results in adults, but pediatric data are limited so this pediatric application is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Provision of signed and dated informed consent form * Male or female * Age: birth to 21 years of age * Equipped with a central venous catheter (CVC) for central venous pressure (CVP) monitoring indication as part of standard of care, or undergoing cardiac catheterization. Exclusion Criteria: * Weight less than 2.5kg at the time of enrollment. * Bilateral external jugular veins not accessible due to vascular access or dressing. * Bilateral skin lesion contraindicating neck Ultrasound * Active bleeding * Clinically unstable, per clinical assessment by attending physician and/or surgeon
Where it's running
-
Children's National Hospital
Washington D.C., District of Columbia, United States Recruiting
Study contacts
- Study coordinator: Damon Judges
- Email: d.judges@compremium.ch
- Phone: +41775071995
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing HVPG and endoscopic ultrasound portal pressure measurements
This study will test whether an endoscopic ultrasound method (EUS-PPG) gives the same portal pressure readings as the standard hepatic venous pressure gradient (HVPG) in adults who need portal pressure measurement.
-
Frailty and Ultrasound-Guided Catheterization in Adult Cardiac Surgery Patients
This study tests whether frailty and ultrasound measurements taken before surgery can predict how difficult it will be to place an ultrasound-guided internal jugular venous catheter in adults undergoing elective cardiac surgery.
-
Which CVC dressing securement helps prevent MARSI best
This study tests three dressing strategies (acrylic tape, silicone tape, and barrier film with acrylic tape) to see which best prevents MARSI in adults with central venous catheters.
-
Central venous catheter placement with bedside ECG guidance and thoracic ultrasound
This study tests whether using intracavity ECG to confirm catheter tip position and bedside ultrasound to check for pneumothorax is feasible compared with standard post-procedure X-rays.
-
SpadCare: digital home-care program for patients with PICC lines
This program tests a smartphone app that teaches and remotely monitors adults with PICC lines who receive home infusions to help reduce catheter complications.
-
Improving prevention of catheter-related bloodstream infections in ICUs
This study is testing a new approach to help hospitals in intensive care units prevent infections related to catheters by making sure doctors and nurses follow the best care practices.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.